Francesco Salituro is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of psychedelic and entactogen compounds. His work focuses on the development of innovative treatments for various psychological and central nervous system disorders.

Latest Patents

Francesco holds a patent for "Phenethylamine derivatives, compositions, and methods of use." This patent encompasses the disclosure of psychedelic and entactogen compounds, which are utilized in treating diseases associated with the serotonin 5-HT receptor. The patent also details pharmaceutical compositions, including tablet compositions and kits containing these compounds. Furthermore, it outlines methods for delivering the compounds via inhalation in a mist form, as well as methods for treating disorders linked to the serotonin 5-HT receptor.

Career Highlights

Francesco Salituro has achieved recognition for his innovative approaches in the pharmaceutical field. His work has the potential to revolutionize treatments for central nervous system disorders and psychological conditions. He is currently associated with Cybin IRL Limited, where he continues to advance his research and development efforts.

Collaborations

Francesco collaborates with talented individuals in his field, including Alex Belser and Clinton E Canal. These partnerships enhance the scope and impact of his work, fostering a collaborative environment for innovation.

Conclusion

Francesco Salituro is a pioneering inventor whose work in psychedelic compounds holds promise for the treatment of various psychological and CNS disorders. His contributions to the field are significant and continue to shape the future of pharmaceutical innovations.

Profile summary based on public USPTO records.